Research Galmed and Gannex Expand Development Programs For NASH Through Research Collaboration of Aramchol and ASC41 (THR-beta Agonist) RachelNovember 30, 2020
Research NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications RachelOctober 19, 2020
